Klatzmann, David,Saadoun, David,Cacoub, Patrice,Rosenzwajg, Michele,Piaggio, Eliane,Bensimon, Gilbert,Bernard, Claude
申请号：
AU2012228418
公开号：
AU2012228418B2
申请日:
2012.03.09
申请国别(地区):
AU
年份:
2016
代理人:
摘要：
The present invention relates to novel therapies for treating autoimmune and inflammatory diseases. More specifically, the present invention relates to a use of low dose interleukin-2 for the treatment of type I diabetes and other autoimmune and/or inflammatory diseases.
